TARDIO JASON (Chief Commercial Officer) sold 17.34K shares of OVID THERAPEUTICS INC. on the open market
Open‑market sale worth $37.3K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2022ACC: 0001209191-22-049938
Officer· Chief Commercial Officer
Since Nov 2019
-17.34K
Net shares
Net seller
$37.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
17.34K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−17.34K
Price / share
$2.15
Trade value
$37.29K
% of position
New position
9/12/2022
17.34K→0.00
Total
Net shares
−17.34K
Net value
-$37.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2022 | S · Sale | −17.34K | $2.15 | $37.29K | New position | 17.34K | 0.00 |
| Total | −17.34K | -$37.29K | ||||||
Derivative Transactions0
No derivative transactions reported